Export your current network:
... as a vector graphic:
SVG: scalable vector graphic - can be opened and edited in Illustrator, CorelDraw, Dia, etc
... as short tabular text output:
TSV: tab separated values - can be opened in Excel and Cytoscape (lists only one-way edges: A-B)
... as tabular text output:
TSV: tab separated values - can be opened in Excel (lists reciprocal edges: A-B,B-A)
... as an XML summary:
structured XML interaction data, according to the 'PSI-MI' data standard
... protein node degrees:
node degree of proteins in your network (given the current score cut-off)
... network coordinates:
a flat-file format describing the coordinates and colors of nodes in the network
... protein sequences:
MFA: multi-fasta format - containing the aminoacid sequences in the network
... protein annotations:
a tab-delimited file describing the names, domains and descriptions of proteins in your network
... functional annotations:
a tab-delimited file containing all known functional terms of protiens in your network
Browse interactions in tabular form:
| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ASPHD2 | BLMH | ENSOCUP00000042845 | ENSOCUP00000035232 | Aspartate beta-hydroxylase domain containing 2. | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | 0.612 |
| BLMH | ASPHD2 | ENSOCUP00000035232 | ENSOCUP00000042845 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | Aspartate beta-hydroxylase domain containing 2. | 0.612 |
| BLMH | CASP14 | ENSOCUP00000035232 | ENSOCUP00000021721 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | Caspase 14; Belongs to the peptidase C14A family. | 0.797 |
| BLMH | CASP16 | ENSOCUP00000035232 | ENSOCUP00000000197 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | Uncharacterized protein; Belongs to the peptidase C14A family. | 0.803 |
| BLMH | CLPB | ENSOCUP00000035232 | ENSOCUP00000043292 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | ClpB homolog, mitochondrial AAA ATPase chaperonin. | 0.591 |
| BLMH | ERAP1 | ENSOCUP00000035232 | ENSOCUP00000006764 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | Endoplasmic reticulum aminopeptidase 1. | 0.705 |
| BLMH | NPEPPS | ENSOCUP00000035232 | ENSOCUP00000023664 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | Aminopeptidase. | 0.645 |
| BLMH | NUDT12 | ENSOCUP00000035232 | ENSOCUP00000015142 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | Nudix hydrolase 12. | 0.718 |
| BLMH | SPATA4 | ENSOCUP00000035232 | ENSOCUP00000011674 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | Spermatogenesis associated 4. | 0.607 |
| BLMH | TMIGD1 | ENSOCUP00000035232 | ENSOCUP00000003164 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | Transmembrane and immunoglobulin domain containing 1. | 0.582 |
| BLMH | TPP2 | ENSOCUP00000035232 | ENSOCUP00000012294 | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | Tripeptidyl peptidase 2. | 0.662 |
| CASP14 | BLMH | ENSOCUP00000021721 | ENSOCUP00000035232 | Caspase 14; Belongs to the peptidase C14A family. | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | 0.797 |
| CASP16 | BLMH | ENSOCUP00000000197 | ENSOCUP00000035232 | Uncharacterized protein; Belongs to the peptidase C14A family. | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | 0.803 |
| CLPB | BLMH | ENSOCUP00000043292 | ENSOCUP00000035232 | ClpB homolog, mitochondrial AAA ATPase chaperonin. | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | 0.591 |
| ERAP1 | BLMH | ENSOCUP00000006764 | ENSOCUP00000035232 | Endoplasmic reticulum aminopeptidase 1. | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | 0.705 |
| ERAP1 | TPP2 | ENSOCUP00000006764 | ENSOCUP00000012294 | Endoplasmic reticulum aminopeptidase 1. | Tripeptidyl peptidase 2. | 0.647 |
| NPEPPS | BLMH | ENSOCUP00000023664 | ENSOCUP00000035232 | Aminopeptidase. | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | 0.645 |
| NPEPPS | TPP2 | ENSOCUP00000023664 | ENSOCUP00000012294 | Aminopeptidase. | Tripeptidyl peptidase 2. | 0.468 |
| NUDT12 | BLMH | ENSOCUP00000015142 | ENSOCUP00000035232 | Nudix hydrolase 12. | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | 0.718 |
| SPATA4 | BLMH | ENSOCUP00000011674 | ENSOCUP00000035232 | Spermatogenesis associated 4. | Bleomycin hydrolase; The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. | 0.607 |
page 1 of 2